drugset / Trial / NCT00464334
A Study of V950 in People With Alzheimer Disease (V950-001 AM7)
RandomizedParallel-groupDouble-blindDiagnostic
Summary
The purpose of this study is to test the safety, tolerability and the immune response to an investigational vaccine, V950, with or without ISCOMATRIX™ (IMX).
Timeline
- Start
- 2007-03
- Primary completion
- 2012-01
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ISCOMATRIX | Unknown | 0 ug | Intramuscular |
| Subject | ISCOMATRIX | Unknown | 16 ug | Intramuscular |
| Subject | ISCOMATRIX | Unknown | 47 ug | Intramuscular |
| Subject | ISCOMATRIX | Unknown | 94 ug | Intramuscular |
| Subject | V950 | Vaccine | 0.5 ug | Intramuscular |
| Subject | V950 | Vaccine | 5 ug | Intramuscular |
| Subject | V950 | Vaccine | 50 ug | Intramuscular |